PEAK6 Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-21,700
Closed -$1.69M 5062
2016
Q2
$1.69M Sell
21,700
-15,300
-41% -$1.09M 0.01% 1374
2016
Q1
$2.04M Buy
37,000
+16,500
+80% +$899K 0.02% 1149
2015
Q4
$1.27M Sell
20,500
-79,200
-79% -$5M 0.01% 1719
2015
Q3
$6.29M Sell
99,700
-33,300
-25% -$2.38M 0.03% 731
2015
Q2
$9.72M Buy
133,000
+69,000
+108% +$4.98M 0.06% 451
2015
Q1
$4.19M Buy
64,000
+51,000
+392% +$3.39M 0.03% 782
2014
Q4
$845K Sell
13,000
-78,300
-86% -$5.04M 0.01% 2099
2014
Q3
$5.49M Sell
91,300
-3,300
-3% -$216K 0.04% 603
2014
Q2
$6.55M Buy
94,600
+29,900
+46% +$1.94M 0.06% 391
2014
Q1
$4.23M Sell
64,700
-65,500
-50% -$4.26M 0.04% 739
2013
Q4
$8.07M Sell
130,200
-213,200
-62% -$12.3M 0.06% 431
2013
Q3
$9.22M Buy
343,400
+328,000
+2,130% +$16.9M 0.06% 375
2013
Q2
$703 Buy
+15,400
New +$667K ﹤0.01% 2467

Other funds holding STJ

PEAK6 Group's STJ Position: Q1 2017 in Review

PEAK6 Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 59,968 shares — an estimated $4.81M sold.

PEAK6 Group first reported a position in STJ in Q4 2014 and held it in 3 quarters. The position peaked at $4.81M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • PEAK6 Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 59,968 St Jude Medical shares in Q1 2017, an estimated $4.81M.
  • PEAK6 Group first reported a position in St Jude Medical in Q4 2014 and held it in 3 quarters.
  • PEAK6 Group's St Jude Medical position peaked at $4.81M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.